{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:11:03Z","timestamp":1760299863832,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.schres.2019.11.028","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T09:03:36Z","timestamp":1579511016000},"page":"332-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Slow your role: How slowing clozapine titration can prevent recurrent NMS"],"prefix":"10.1016","volume":"218","author":[{"given":"Rohn","family":"Nahmias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areef","family":"Kassam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.schres.2019.11.028_bb0005","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11126-014-9291-9","article-title":"Rechallenging clozapine after neuroleptic malignant syndrome","volume":"85","author":"Anbalagan","year":"2014","journal-title":"Psychiatric Q."},{"issue":"12","key":"10.1016\/j.schres.2019.11.028_bb0010","article-title":"Antipsychotic dose escalation as a trigger for Neuroleptic Malignant Syndrome (NMS): literature review and case series report","volume":"214","author":"Langan","year":"2012","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2019.11.028_bb0015","first-page":"256","article-title":"A case of recurrent neuroleptic malignant syndrome","volume":"25","author":"Ouyang","year":"2013","journal-title":"Arch. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2019.11.028_bb0020","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1592\/phco.28.4.530","article-title":"Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations","volume":"28","author":"Picard","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.schres.2019.11.028_bb0025","article-title":"Neuroleptic malignant syndrome: diagnosis and management","volume":"20","author":"Ware","year":"2014","journal-title":"Prim. Care Companion CNS Disord."},{"issue":"6","key":"10.1016\/j.schres.2019.11.028_bb0030","first-page":"475","article-title":"Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review","volume":"22","author":"Wells","year":"1988","journal-title":"Drug Intell. Clin. Pharm."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419305365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419305365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:34:42Z","timestamp":1760297682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996419305365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":6,"alternative-id":["S0920996419305365"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2019.11.028","relation":{},"ISSN":["0920-9964"],"issn-type":[{"type":"print","value":"0920-9964"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Slow your role: How slowing clozapine titration can prevent recurrent NMS","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2019.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}